Asthma Prophylactics

All the Therapeutic System Drugs

Monoclonal Antibody. Reslizumab 10 mg/ml.
VIAL(Concent. for sol. for infus.): 1×10ml, 100ml. IV infus. only. Do not admin. as an IV push or bolus. The recomm. regimen is 3 mg/kg once every 4 wks. admin. by IV infus. over 20-50 min. Discont. the infus. immed. if the pt. experience. a sev. syst. react., including anaphylaxis.
Indic. for the add-on mainten. tmt. of pts. with sev. asthma aged 18 yrs. and older with an eosinophilic phenotype.
C/I: Hypersens.

Flixotide Nebules

Corticosteroid. Fluticasone Propionate 0.5 mg / 2 ml, 2 mg/ 2 ml.
AMPS FOR NEBULIZAT: 2 ml x 0.5 mg, 2
mg. 500 μg-2,000 μg 2 x dly, adjust.
dose as reqd. Child and adolesc. from
4-16 yrs: 1,000 μg 2 x dly.
Proph. severe asth., tmt. acute exacerb.
asth. in adults, child. and adolesc. 4-16 yrs
and over.

Montair 4 mg, 5 mg

Montelukast Teva 10 mg

Leukotriene Receptor Antagonist. Montelukast Sodium 10 mg.
TABS: 28 x 10 mg. Asthma, season.
allerg., rhinit: 1 tab dly in even. Season.
allerg. rhinit: Individual. Asthma,
season. allerg., rhinit: Adults, > 15 yrs:
1 x 10 mg dly.
Proph./chron. tmt asthma includ. day/
night sympts., aspirin sens., excerciseinduced
bronchoconstrict. Alone or in
comb. other agents maint. tmt chron.
asthma, inhaled coricosteroids used
concom. with additive effect to control
asthma/reduced inhaled corticosteroid
dose while maint. clin. stabil.
C/I: Hypersens. See lit.

Montelukast Teva 4 mg, 5 mg

Leukotriene Receptor Antagonist. Montelukast Sodium 4 mg, 5 mg.
CHEW TABS: 28 x 4 mg, 5 mg.
Asthma, season. allerg., rhinit: 1 tab dly in even. Season. allerg. rhinit: Individual. Asthma, season. allerg., rhinit: Adults, > 15 yrs: 1 x 10 mg dly. Ped: 6-14 yrs: 1 x 5 mg chew tab dly; 2-5 yrs: 1 x 4 mg chew
tab dly. Can be added to exist. regimen
(bronchodilats., inhaled corticosteroids). See lit.
Proph./chron.tmt asthma includ. day/
night sympts., aspirin sens., excerciseinduced
bronchoconstrict. Alone or in
comb. other agents maint. tmt chron.
asthma, inhaled coricosteroids used
concom. with additive effect to control
asthma/reduced inhaled corticosteroid
dose while maint. clin. stabil.
C/I: Hypersens. See lit.

Nucala

Monoclonal Antibody. Mepolizumab 100 mg.
VIAL-1×10ml.: 100 mg SC once every 4 wks. Intended for long-term tmt. See lit.
Add-on tmt. for severe refract. eosinophilic asthma in adult pts.
C/I: Hypersens.